On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Physicians Who Take Vacation Time, Avoid Working on Vacation Less Likely to Suffer Burnout
January 12th 2024A survey of more than 3000 US physicians is shedding light on the impact of taking vacation time and avoiding physician-related work on vacation can have on burnout and achieving professional fulfillment.
Prolonged Perfusion Preserves Donor Livers, Allows Flexible Transplantation Timeline
January 12th 2024Liver transplantation after prolonged preservation with dual hypothermic oxygenated machine perfusion yielded similar outcomes to standard perfusion, showing no compromised donor liver quality and equal safety for recipients.
Hepatitis C Genotype, Cirrhosis, Gender May Impact Effectiveness of DAA Therapy
January 11th 2024Although the overall response rate among the cohort was 96.4%, this figure dropped as low as 66.7% when accounting for male gender, GT3 infection, cirrhosis, obesity, and non-response to previous therapy.
Increase in Depressive Symptoms Linked to Further Weight Gain in Overweight, Obesity
January 11th 2024For every increment increase in a participant’s usual score for depressive symptoms, investigators of a new study found weight increased a month later by 45g, only for participants with overweight and obesity.
Hepatitis B Markers, Reactivation Do Not Impact Effectiveness of DAA Therapy for HCV
January 10th 2024Response to direct-acting antiviral therapy was similar between patients with and without HBV coinfection, with most patients completing the planned course of treatment and achieving SVR, even in the case of HBV reactivation.
Long-Term Efficacy of Risankizumab Observed for Psoriasis Regardless of Disease Characteristics
These data indicate a significant ability of this treatment to address patients’ psoriatic symptoms in a comprehensive manner, despite varying characteristics and demographics.
Risk Factors for IgA Nephropathy Recurrence After Kidney Transplant
January 10th 2024Younger age at the time of kidney transplantation, faster progression to end-stage renal disease, a history of kidney transplantation, and no induction therapy were associated with IgAN recurrence, which was linked to poorer graft survival.